Bob Snow/Lancet Infect Dis

7 results

Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems.Talisuna AO, Karema C, Ogutu B, Juma E, Logedi J, Nyandigisi A, Mulenga M, Mbacham WF, Roper C, Guerin PJ, D'Alessandro U, Snow RW
Lancet Infect Dis, (2012). 12:888-96

Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data.van Eijk AM, Hill J, Alegana VA, Kirui V, Gething PW, ter Kuile FO, Snow RW
Lancet Infect Dis, (2011). 11:190-207

Measuring malaria endemicity from intense to interrupted transmission.Hay SI, Smith DL, Snow RW
Lancet Infect Dis, (2008). 8:369-78

The global distribution and population at risk of malaria: past, present, and future.Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW
Lancet Infect Dis, (2004). 4:327-36

Global warming and malaria: a call for accuracy.Reitera P, Thomas CJ, Atkinson PM, Hay SI, Randolph SE, Rogers DJ, Shanks GD, Snow RW, Spielman A
Lancet Infect Dis, (2004). 4:323-4

Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy.Korenromp EL, Williams BG, Gouws E, Dye C, Snow RW
Lancet Infect Dis, (2003). 3:349-58

Scaling-up coverage with insecticide-treated nets against malaria in Africa: who should pay?.Curtis C, Maxwell C, Lemnge M, Kilama WL, Steketee RW, Hawley WA, Bergevin Y, Campbell CC, Sachs J, Teklehaimanot A, Ochola S, Guyatt H, Snow RW
Lancet Infect Dis, (2003). 3:304-7